Does obesity predict morbidity and mortality amongst patients undergoing transfemoral amputations?

Abstract

Background We investigated the role of obesity on morbidity and mortality in patients undergoing above knee amputation. Methods Data of 4225 patients undergoing AKAs was extracted from NIS Database (2016–2019) for a retrospectively matched case-control study and were grouped into; Non-obese (N-Ob-BMI <29.9 kg/m2; n = 1413), class I/II obese (Ob-I/II-BMI: 30–39.9 kg/m2; n = 1413), and class III obese groups (Ob-IIIBMI > 40; n = 1399). Morbidity, mortality, length of stay, and hospital charges were analyzed. Results Blood loss anemia (OR = 1.42; 95% CI = 1.19–1.64), superficial SSI (OR = 5.10; 95% CI = 1.4717.63) and acute kidney injury (AKI- OR = 1.42; 95% CI = 1.21–1.67) were higher in Ob-III patients. Mortality was 5.8%, 4.5%, and 6.4% in N-Ob, Ob-I/II and Ob-III patients ( p < 0.001; Ob-I/II vs. Ob-III), respectively. Hospital LOS was 3 days higher in Ob-III (16.1 ± 18.0), comparatively resulting in $25,481 higher inpatient-hospital charge. Conclusion Patients in Ob-III group were noted to have increased morbidity, higher LOS, and inpatient-hospital cost.